AGIOS PHARMACEUTICALS, INC. (AGIO) insider trading

By person

16 insiders · 3 transactions

8.2×

Brian Goff holds 8.2 times base salary in stock. $6.95M of shares against $846.86K in salary for 2025.

Salary from the company's own proxy. The shares are what Brian Goff last reported holding, valued at $37.69, the price Common stock was last bought or sold at on the open market here, on 26 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sarah Gheuens

Chief Medical Officer

—

$371.11K (3) scheduled

−$371.11K

54,645

0.0915%

$2.06M

+21.0%

Brian Goff

Chief Executive Officer

—

184,508

0.3090%

$6.95M

+134.2%

Jacqualyn A Fouse

Director

—

154,156

0.2582%

$5.81M

+9.5%

Cecilia Jones

Chief Financial Officer

—

54,998

0.0921%

$2.07M

+159.4%

James William Burns

Chief Legal Officer

—

49,306

0.0826%

$1.86M

+30.8%

Tsveta Milanova

Chief Commercial Officer

—

46,829

0.0784%

$1.76M

+253.9%

David Scadden

Director

—

20,419

0.0342%

$769.59K

+31.9%

Maykin Ho

Director

—

19,848

0.0332%

$748.07K

+33.1%

Rahul D. Ballal

Director

—

15,230

0.0255%

$574.02K

+90.6%

Cynthia Smith

Director

—

15,230

0.0255%

$574.02K

+90.6%

Adams Catherine Owen

Director

—

10,865

0.0182%

$409.50K

+449.8%

Jeffrey D Capello

Director

—

10,865

0.0182%

$409.50K

+449.8%

Kaye I Foster-Cheek

Director

—

10,284

0.0172%

$387.60K

+92.3%

Krishnan Viswanadhan

Chief Strategy and Operations

—

10,282

0.0172%

$387.53K

—

Jay T. Backstrom

Director

—

1,447

0.0024%

$54.54K

—

Theodore James Washburn Jr.

Principal Accounting Officer

—

868

0.0015%

$32.71K

−47.1%

AGIOS PHARMACEUTICALS, INC.

What the insiders did Scheduled selling only

By person